PEDIATRIC VACCINES MARKET ANALYSIS

Pediatric Vaccines Market, By Vaccine Type (Pneumococcal Vaccine, DTP Vaccine, Rotavirus Vaccine, MMR Vaccine, Polio Vaccine, Influenza Vaccine, Hepatitis B Vaccine, Meningococcal Vaccine, Hib Vaccine, Varicella Vaccine), By Technology (Live or Attenuated Vaccine, Inactivated or Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023
Code : CMI1708
Pages :190
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Restraints & Challenges:

Adverse events after vaccination

Adverse effects after vaccination

The major factors that can hamper growth of the global pediatric vaccines market over the forecast period include serious adverse events after COVID-19 boosters in young kids. For instance, on August 18, 2022, The University of Minnesota, U.S., published the data collected from two vaccine safety surveillance programs in the first 10 weeks of administration of third doses of the Pfizer/BioNTech COVID-19 vaccine to children aged 5 to 11 years in the U.S., and it had serious adverse effects such as injection-site pain, fatigue, and headache.

Therefore, study of adverse effects occurred during treatment is required for treatment improvisation which expected to drive the growth of market in near future.

PEDIATRIC VACCINES MARKET ANALYSIS

Market Challenges And Opportunities

Pediatric Vaccines Market Report Snapshots

EXISTING CLIENTELE